| Literature DB >> 25139256 |
Fadi El-Jardali, Elie A Akl1, Lama Bou Karroum, Ola Kdouh, Chaza Akik, Racha Fadlallah, Rawan Hammoud.
Abstract
BACKGROUND: Systematic reviews can offer policymakers and stakeholders concise, transparent, and relevant evidence pertaining to pressing policy priorities to help inform the decision-making process. The production and the use of systematic reviews are specifically limited in the Eastern Mediterranean region. The extent to which published systematic reviews address policy priorities in the region is still unknown. This situational analysis exercise aims at assessing the extent to which published systematic reviews address policy priorities identified by policymakers and stakeholders in Eastern Mediterranean region countries. It also provides an overview about the state of systematic review production in the region and identifies knowledge gaps.Entities:
Mesh:
Year: 2014 PMID: 25139256 PMCID: PMC4237801 DOI: 10.1186/1478-4505-12-48
Source DB: PubMed Journal: Health Res Policy Syst ISSN: 1478-4505
Systematic reviews matched with the policy-relevant priorities identified in El-Jardali et al. [12]and Rashidian et al. [13]by theme
| | ||
| Means to develop HRH information systems in ministries of health and national observatories | 0 (0.0) | |
| Gaps in existing education and training programs | 0 (0.0) | |
| Information on patient satisfaction | 1 (0.9) | |
| Accurate estimates and needs in numbers and specialties (mapping) | 4 (3.5) | |
| Ways that can enable education and training programs to meet the population health needs | 30 (26.1) | |
| Methods to measure HRH performance and productivity | 0 (0.0) | |
| Develop simulation models for HRH planning | 30 (26.1) | |
| Elements of performance evaluation | 7 (6.1) | |
| Develop incentive mechanisms to better manage the existing stock of HRH | 18 (15.7) | |
| Ways to improve staff satisfaction | 25 (21.7) | |
| | ||
| Elements of an equitable health financing system | 13 (39.3) | |
| Household ability to pay for healthcare | 16 (48.4) | |
| Linking population health needs to health spending | 2 (6.1) | |
| Role of the social health insurance system in guaranteeing equity | 1 (3.0) | |
| Identifying best practices to develop and implement a national social health insurance system | 9 (27.2) | |
| Clarifying functions and coordination processes between ministries (for example, the ministries of health and of finance) to improve health system financing and quality of services | 0 (0.0) | |
| Means to track financial resources invested in health care to ensure value for money | 0 (0.0) | |
| Accurate estimation of the health expenditure from the public and the private sectors including out-of-pocket expenditure | 0 (0.0) | |
| Population health status and needs | 0 (0.0) | |
| | ||
| Ways to regulate and monitor the quality of care in the private sector | 16 (64.0) | |
| Ways to optimize the use of the existing resources of the non-state sector to meet health system objectives | 4 (16.0) | |
| Ways for the public and private sectors to complement their service delivery | 4 (16.0) | |
| Areas where the state and civil society groups can complement each other | 0 (0.0) | |
| National database on the non-state sector | 0 (0.0) | |
| Foundation/elements for building strong public-private partnerships | 1 (4.0) | |
| Accreditation standards for private sector | 0 (0.0) | |
| Ways to develop effective contracting mechanisms with the private and other non-state sectors | 3 (12.0) | |
| National plan for the contribution of the non-state sector | 0 (0.0) | |
| Measuring client satisfaction | 0 (0.0) | |
| Defining the role and responsibility of the non-state sector | 0 (0.0) | |
| Scope, resources, and kind of services provided by the non-state sector | 0 (0.0) | |
| | ||
| Evaluation the role of pharmaceutical companies on prescribing and drug use patterns | 5 (18.5) | |
| Identifying effective continuous education methods for physicians to improve drug use patterns and access to medicines | 8 (29.6) | |
| What happens at the dispensary? Dispensing medicines or delivering primary health care? | 2 (7.4) | |
| Identifying effective methods on improving public knowledge and awareness about drug use | 3 (11.1) | |
| Consumer demand, health-seeking preferences, willingness to pay, and enhancing patient role in accountability | 0 (0.0) | |
| Assessing the procedures and regulations for adding medicines to the national drug list (formulary) and identifying improvement models | 0 (0.0) | |
| Adherence to generics in primary health care and dispensaries | 1 (3.7) | |
| Attitudes of physicians and of the public towards generic substitution and the opportunities for implementing relevant policies | 0 (0.0) | |
| Pricing policies to improve access to essential generics and contain prices of excessively priced originator brands | 0 (0.0) | |
| Evaluation of the effect of the ‘single item importing’ policy on final cost of medicines, quality and access, and health system expenditure | 0 (0.0) | |
| Evaluation of the process of adding medicines to the insurance organizations' list of medicines covered | 0 (0.0) | |
| Alternative financing mechanisms to supplement public sector provision | 12 (44.4) | |
| Optimal mix of pricing regulations to reduce expenditure burden on households | 1 (3.7) | |
| Assessment of quality of medicines on the market and role of counterfeit medicines and black market | 0 (0.0) | |
| Improving logistics and human resource management in the public sector for improving drug access | 0 (0.0) | |
| Evaluation of the role of civil society organizations and non-governmental organizations in improving access to medicines especially for the poor, vulnerable groups, and hard-to-reach populations | 0 (0.0) | |
| Mapping and assessment of private sector including of qualified providers, informal providers, shadow pharmacies, and traditional healers | 0 (0.0) |
Figure 1Planned activities of the WHO Center for systematic reviews on health policy and systems research.
Figure 2Phases of the study methodology.
Figure 3Selection process flowchart.
Figure 4Extent to which the identified systematic reviews addressed EMR priorities by theme.
Figure 5Themes stratified by sub-themes.
State of production and contribution of the Eastern Mediterranean region (EMR) to systematic reviews (SRs)
| Total SRs addressing policy-relevant research priorities | 200 (19.1%) |
| SRs including primary studies conducted in the EMR | 17 (8.5) |
| SRs produced by at least one author based in the EMR | 3 (1.5) |
| SRs with EMR as the target jurisdiction | 0 (0.0) |
Figure 6EMR countries with primary studies and authors contributing to systematic reviews.